Literature DB >> 26211600

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Ayalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, Lawrence H Baker, Jan L Abkowitz, John W Adamson, Ranjana Hira Advani, James Allison, Karen H Antman, Robert C Bast, John M Bennett, Edward J Benz, Nancy Berliner, Joseph Bertino, Ravi Bhatia, Smita Bhatia, Deepa Bhojwani, Charles D Blanke, Clara D Bloomfield, Linda Bosserman, Hal E Broxmeyer, John C Byrd, Fernando Cabanillas, George Peter Canellos, Bruce A Chabner, Asher Chanan-Khan, Bruce Cheson, Bayard Clarkson, Susan L Cohn, Gerardo Colon-Otero, Jorge Cortes, Steven Coutre, Massimo Cristofanilli, Walter J Curran, George Q Daley, Daniel J DeAngelo, H Joachim Deeg, Lawrence H Einhorn, Harry P Erba, Francisco J Esteva, Elihu Estey, Isaiah J Fidler, James Foran, Stephen Forman, Emil Freireich, Charles Fuchs, James N George, Morie A Gertz, Sergio Giralt, Harvey Golomb, Peter Greenberg, Jordan Gutterman, Robert I Handin, Samuel Hellman, Paulo Marcelo Hoff, Ronald Hoffman, Waun Ki Hong, Mary Horowitz, Gabriel N Hortobagyi, Clifford Hudis, Jean Pierre Issa, Bruce Evan Johnson, Philip W Kantoff, Kenneth Kaushansky, David Khayat, Fadlo R Khuri, Thomas J Kipps, Margaret Kripke, Robert A Kyle, Richard A Larson, Theodore S Lawrence, Ross Levine, Michael P Link, Scott M Lippman, Sagar Lonial, Gary H Lyman, Maurie Markman, John Mendelsohn, Neal J Meropol, Yoav Messinger, Therese M Mulvey, Susan O'Brien, Roman Perez-Soler, Raphael Pollock, Josef Prchal, Oliver Press, Jerald Radich, Kanti Rai, Saul A Rosenberg, Jacob M Rowe, Hope Rugo, Carolyn D Runowicz, Brenda M Sandmaier, Alan Saven, Andrew I Schafer, Charles Schiffer, Mikkael A Sekeres, Richard T Silver, Lillian L Siu, David P Steensma, F Marc Stewart, Wendy Stock, Richard Stone, Rainer Storb, Louise C Strong, Martin S Tallman, Michael Thompson, Naoto T Ueno, Richard A Van Etten, Julie M Vose, Peter H Wiernik, Eric P Winer, Anas Younes, Andrew D Zelenetz, Charles A LeMaistre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26211600      PMCID: PMC5365030          DOI: 10.1016/j.mayocp.2015.06.001

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  3 in total

Review 1.  Why are cancer drugs so expensive in the United States, and what are the solutions?

Authors:  Hagop Kantarjian; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2015-03-16       Impact factor: 7.616

2.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Authors:  S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy
Journal:  Oncologist       Date:  2013-02-26

3.  Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia.

Authors:  Stacie B Dusetzina; Aaron N Winn; Gregory A Abel; Haiden A Huskamp; Nancy L Keating
Journal:  J Clin Oncol       Date:  2013-12-23       Impact factor: 44.544

  3 in total
  42 in total

1.  Medicine: Eyes on the target.

Authors:  Michael Eisenstein
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

2.  America's drug problem.

Authors:  Brady Huggett
Journal:  Nat Biotechnol       Date:  2016-11-14       Impact factor: 54.908

3.  The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology.

Authors: 
Journal:  J Oncol Pract       Date:  2016-03-15       Impact factor: 3.840

4.  Dynamic Assessment of Value During High-Cost Cancer Treatment: A Response to American Society of Clinical Oncology and European Society of Medical Oncology.

Authors:  Charles W Given; Barbara A Given; Cathy J Bradley; John C Krauss; Alla Sikorskii; Eric Vachon
Journal:  J Oncol Pract       Date:  2016-10-31       Impact factor: 3.840

5.  Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.

Authors:  Deborah C Marshall; Beverly Moy; Madeleine E Jackson; Tim K Mackey; Jona A Hattangadi-Gluth
Journal:  J Natl Cancer Inst       Date:  2016-07-07       Impact factor: 13.506

6.  Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry-Defining the "Goods" at Stake.

Authors:  Narcyz Ghinea; Miles Little; Wendy Lipworth
Journal:  J Bioeth Inq       Date:  2017-07-18       Impact factor: 1.352

7.  Challenges and Opportunities in Adapting Clinical Trial Design for Immunotherapies.

Authors:  Lillian L Siu; S Percy Ivy; Erica L Dixon; Amy E Gravell; Steven A Reeves; Gary L Rosner
Journal:  Clin Cancer Res       Date:  2017-09-01       Impact factor: 12.531

8.  Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

Authors:  Scott K Sherman; Joel J Lange; Fadi S Dahdaleh; Rahul Rajeev; T Clark Gamblin; Blase N Polite; Kiran K Turaga
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

9.  Oncologist Support for Consolidated Payments for Cancer Care Management in the United States.

Authors:  Siva Narayanan; Emily Hautamaki
Journal:  Am Health Drug Benefits       Date:  2016-07

10.  Exploring barriers to the receipt of necessary medical care among cancer survivors under age 65 years.

Authors:  Matthew P Banegas; John F Dickerson; Erin E Kent; Janet S de Moor; Katherine S Virgo; Gery P Guy; Donatus U Ekwueme; Zhiyuan Zheng; Stephanie Nutt; Loyce Pace; Alexandra Varga; Lisa Waiwaiole; Jennifer Schneider; K Robin Yabroff
Journal:  J Cancer Surviv       Date:  2017-08-29       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.